Примери за използване на Pharmacovigilance system на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
those arrangements shall be set out in details in the pharmacovigilance system master file.
Stronger involvement of patients in the reporting on side effects is an integral part of Europe's pharmacovigilance system and- once in place- the new symbol will contribute to strengthen what is already one of the most advanced systems in the world.".
The marketing authorisation holder shall have in place one or more pharmacovigilance system master files describing in details the pharmacovigilance system with respect to.
the Member States shall establish a pharmacovigilance system.
Revising these proposals has also been an opportune moment to further strengthen the current system for monitoring the safety of medicines(known as the pharmacovigilance system) in the European Union.
shall remain responsible for the marketing authorisation holder's pharmacovigilance system and for the safety profile of his veterinary medicinal products.
enabling them to fulfil their pharmacovigilance responsibilities(‘pharmacovigilance system').
The marketing authorisation holder shall have in place one or more pharmacovigilance system master files describing in detail the pharmacovigilance system with respect to its authorised veterinary medicinal products.
as described in the document“ Description of the PharmacoVigilance system” submitted on 16 November 2005,
(4) The State Agency of Medicines draws up a report on the audit of the pharmacovigilance system and submit it to the European Commission not later than by 21 September 2013 and thereafter once every two years.
The competent authorities and the[…] Agency[…] shall ensure that all pharmacovigilance system master files in the Union[…] are regularly checked and that the pharmacovigilance systems are being correctly applied.
The participants stressed that the pharmacovigilance system should be supported by fees,
(4) The State Agency of Medicines will draw up a report on the audit of the pharmacovigilance system and submit it to the European Commission not later than by 21 September 2013 and thereafter once every two years.
Pharmaceutical companies would only have to present a simplified"pharmacovigilance system master file" in support of the marketing authorisation, provided a detailed
(a) elaborating and maintaining a detailed description of the pharmacovigilance system used by the marketing authorisation holder with respect to the veterinary medicinal product for which the authorisation has been granted(‘pharmacovigilance system master file') for all products under their responsibility;
sets out minimum requirements for the pharmacovigilance system applied at NCA level).
product is manufactured and reference numbers to the pharmacovigilance system master file;
also on the format and content of the pharmacovigilance system master file and its summary.
maintaining a detailed description of the pharmacovigilance system used by the marketing authorisation holder with respect to the veterinary medicinal product for which the authorisation has been granted(‘pharmacovigilance system master file')